Share on LinkedInShare on LinkedIn

ARTICLE · 28 FEBRUARY 2020

Federal Circuit's Acetris Decision Addresses Rules For Determining TAA Compliance

Steptoe LLP
Steptoe LLP
Contributor
Steptoe LLP

Steptoe LLP

Steptoe International (UK) LLP has built a strong reputation for providing top-quality regulatory,...

View firm profile
Explore more from Steptoe LLP

In a February 10, 2020 decision, the Federal Circuit (CAFC) affirmed the Court of Federal Claims (COFC) decision.

United StatesGovernment, Public Sector

In a February 10, 2020 decision, the Federal Circuit (CAFC) affirmed the Court of Federal Claims (COFC) decision sustaining a protest that challenged the US Department of Veterans Affairs' (VA) interpretation of what constitutes a "US-made end product" under the Federal Acquisition Regulation (FAR) provisions implementing the Trade Agreements Act (TAA). Acetris Health, LLC v. United States, No. 2018-2399, slip. op. (Fed. Cir. Feb. 10, 2020).1 The CAFC also affirmed the COFC's holding that a procuring agency must make an independent assessment of whether a product qualifies as a "US-made end product" and cannot simply rely on Customs and Border Protection (CBP) country of origin (COO) determinations.2

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from